ADIPOQ and breast cancer: In ERα-negative breast cancer, adiponectin inhibited IGF-1-induced cell migration, whereas in ERα-positive breast cancer, low concentrations of adiponectin promoted IGF-1R phosphorylation and thus enhanced IGF-1/IGF-1R signaling (55, 56).